Easywell Biomedicals, Inc. Statistics
Easywell Biomedicals, Inc. (1799) Stock Statistics & Valuation Metrics
Total Valuation
Easywell Biomedicals, Inc. has a market cap or net worth of TWD 6.16B. The enterprise value is TWD 3.80B.
- Market Cap
- TWD 6.16B
- Enterprise Value
- TWD 3.80B
Share Statistics
Easywell Biomedicals, Inc. has 248,775,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 248,775,900
- Owned by Insiders
- ―
- Owned by Institutions
- 0.07%
Financial Efficiency
Easywell Biomedicals, Inc.’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -5.95%.
- Return on Equity (ROE)
- -0.11
- Return on Assets (ROA)
- -0.06
- Return on Invested Capital (ROIC)
- -5.95%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 191.60K
- Profits Per Employee
- -23.46K
- Employee Count
- 3,118
- Asset Turnover
- 0.46
- Inventory Turnover
- 2.22
Valuation Ratios
The current PE Ratio of Easywell Biomedicals, Inc. is -194.23. Easywell Biomedicals, Inc.’s PEG ratio is -1.63.
- PE Ratio
- -194.23
- PS Ratio
- 3.94
- PB Ratio
- 4.28
- Price to FCF
- 24.57
- Price to Operating Cash Flow
- 21.39
- PEG Ratio
- -1.63
Income Statement
In the last 12 months, Easywell Biomedicals, Inc. had revenue of 597.41M and earned -73.14M in profits. Earnings per share was -0.59.
- Revenue
- 597.41M
- Gross Profit
- 245.71M
- Operating Income
- -67.20M
- Pretax Income
- -75.18M
- Net Income
- -73.14M
- EBITDA
- 23.93M
- Earnings Per Share (EPS)
- -0.59
Cash Flow
In the last 12 months, operating cash flow was 141.91M and capital expenditures -13.78M, giving a free cash flow of 128.13M billion.
- Operating Cash Flow
- 141.91M
- Free Cash Flow
- 128.13M
- Free Cash Flow per Share
- 1.07
Dividends & Yields
Easywell Biomedicals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.13%
- Earnings Yield
- -0.54%
Stock Price Statistics
- Beta
- 0.50
- 52-Week Price Change
- -34.87%
- 50-Day Moving Average
- 28.37
- 200-Day Moving Average
- 32.69
- Relative Strength Index (RSI)
- 27.55
- Average Volume (3m)
- 128.34K
Important Dates
Easywell Biomedicals, Inc. upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 10, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Easywell Biomedicals, Inc. as a current ratio of 2.52, with Debt / Equity ratio of 61.67%
- Current Ratio
- 2.52
- Quick Ratio
- 1.95
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 6.05
- Interest Coverage Ratio
- -2.99
Taxes
In the past 12 months, Easywell Biomedicals, Inc. has paid 304.00K in taxes.
- Income Tax
- 304.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Easywell Biomedicals, Inc. EV to EBITDA ratio is 40.70, with an EV/FCF ratio of 24.43.
- EV to Sales
- 3.91
- EV to EBITDA
- 40.70
- EV to Free Cash Flow
- 24.43
- EV to Operating Cash Flow
- 22.06
Balance Sheet
Easywell Biomedicals, Inc. has TWD 484.70M in cash and marketable securities with TWD 386.54M in debt, giving a net cash position of TWD 98.16M billion.
- Cash & Marketable Securities
- TWD 484.70M
- Total Debt
- TWD 386.54M
- Net Cash
- TWD 98.16M
- Net Cash Per Share
- TWD 0.39
- Tangible Book Value Per Share
- TWD 5.37
Margins
Gross margin is 46.87%, with operating margin of -0.34%, and net profit margin of -2.03%.
- Gross Margin
- 46.87%
- Operating Margin
- -0.34%
- Pretax Margin
- -1.80%
- Net Profit Margin
- -2.03%
- EBITDA Margin
- 9.62%
- EBIT Margin
- 0.02%
Analyst Forecast
The average price target for Easywell Biomedicals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 32.24%
- EPS Growth Forecast
- 79.83%
